Why the study?
Does atrial antitachycardia pacing safely and effectively convert recurrent atrial tachycardia in patients with repaired congenital heart disease?
Population
18 patients with a variety of congenital heart lesions and recurrent atrial tachycardia after surgical…
Design
Case_series
Follow-up
4-30 months
Authors
Loading...
Sudden death during pacing cautions against use in congenital heart disease; leaves open safety and role pending larger studies.
Does atrial antitachycardia pacing safely and effectively convert recurrent atrial tachycardia in patients with repaired congenital heart disease?
Atrial antitachycardia pacing can successfully terminate atrial reentry tachycardia in congenital heart disease patients but carries a risk of sudden death during pace cardioversion, warranting careful autonomic stress evaluation prior to use.
Rhodes et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: